top of page
  • Writer's pictureDr. Domenico Pratico

Is Alzheimer’s risk higher among women, African-Americans and Hispanics? - Domenico Pratico

Updated: Jan 31

Yes, research suggests that certain demographic groups, including women, African-Americans, and Hispanics, may have a higher risk of developing Alzheimer's disease (AD) compared to other populations.

Is Alzheimer’s risk higher among women, African-Americans and Hispanics - Domenico Pratico

1. Women: Studies have shown that women are more likely to develop AD than men. According to the Alzheimer's Association, almost two-thirds of Americans living with Alzheimer's are women. Some factors contributing to this higher risk include differences in genetics, hormonal changes, and longevity.

2. African-Americans: Research indicates that African-Americans have a higher risk of developing AD compared to Caucasians. The reasons behind this disparity are not fully understood, but factors such as higher rates of vascular diseases, including high blood pressure and diabetes, as well as socioeconomic and educational disparities, may contribute to the increased risk.

3. Hispanics: Studies have also shown that Hispanics have a higher risk of developing AD compared to non-Hispanic whites. Possible factors contributing to this increased risk include a higher prevalence of conditions like diabetes, lower socioeconomic status, and potentially genetic factors.

These observations regarding higher Alzheimer's disease (AD) risk among women, African-Americans, and Hispanics are based on population-level studies, and it is important to remember that not all individuals within these groups will develop AD. Risk factors for AD are multifaceted and can differ among individuals. Factors such as age, family history, lifestyle choices, and overall health also contribute significantly to one's risk of developing the disease.

Awareness of these demographic disparities can aid in the development of targeted prevention strategies, early detection initiatives, and improved access to appropriate healthcare resources for these specific populations.

Domenico Praticò, MD, is the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research, Professor and Director of the Alzheimer’s Center at Temple, and Professor of Pharmacology at the Lewis Katz School of Medicine at Temple University You can find out more information on Dr. Domenico Pratico's research papers here. Connect with Dr. Domenico Pratico on LinkedIn, Facebook, Twitter & Instagram.

Follow Dr Domenico Pratico's lab website here: Pratico Lab

112 views0 comments


bottom of page